ArticleScientific reports2025
Integrating ECG-derived features with conventional CVD risk models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-communicable diseases (NCDs), particularly cardiovascular diseases (CVDs), have become the leading cause of mortality worldwide, with Iran exhibiting higher-than-average incidence and mortality rates. Early detection of high-risk individuals is critical, as CVD often progresses silently. Electrocardiogram (ECG) signals may enhance risk prediction beyond Framingham risk score (FRS). This study aimed to evaluate the predictive performance of ECG signal features for incident CVD using signal processing in a large population-based cohort from the Tehran Lipid and Glucose Study (TLGS). A total of 4,637 adults aged 40 years devoid of past CVD at baseline (2006-2008) were followed up until 2018. Baseline characteristics, laboratory measurements, and ECG signal features were collected. CVD events were defined as coronary heart disease (CHD) or stroke. A recalibrated FRS (baseline) model assessed the association between ECG features and incident CVD, with model performance evaluated using Harrell's C-index, Net Reclassification Index (NRI), and Integrated Discrimination Improvement (IDI). Over a 10-year follow-up, 483 participants (10.4%) developed CVD. The introduction of ECG signal features improved risk prediction in women, increasing the Harrell's C-index from 0.84 to 0.85 and demonstrating significant reclassification improvement (NRI: 55.7%, IDI: 2.8%). However, no meaningful improvement was observed in men. ECG-based modeling outperformed FRS, particularly for intermediate-risk categories among women. Incorporating ECG signal features into risk models significantly enhanced CVD prediction performance in women, suggesting potential utility for improving individualized preventive strategies. Further research is warranted to refine ECG-based risk stratification tools for broader clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.